Acrolein exposure also enhanced production of TGF-β1 (Supplemental Figure 2C), a profibrotic growth factor that is thought to contribute to features of EMT and subepithelial fibrosis in COPD (37–39). Here, TGFB1 is linked to chronic obstructive pulmonary disease.